Vericel (VCEL) Prepaid Assets (2010 - 2026)
Vericel recorded quarterly Prepaid Assets of $8.0 million in Q1 2026, up 3.18% quarter-over-quarter from $7.7 million in Q4 2025, and down 6.2% year-over-year from $8.5 million in Q1 2025.
Vericel's Prepaid Assets history runs 17 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 6.2% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (down 6.2% YoY), while the FY2025 annual figure was $7.7 million, up 6.27% from the prior year.
- Prepaid Assets came in at $8.0 million for Q1 2026 at Vericel, up from $7.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.5 million in Q1 2025 to a low of $4.4 million in Q3 2022.
- A 5-year average of $6.4 million and a median of $6.6 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slipped 10.86% in 2023 and surged 71.26% in 2024, its largest moves.
- Vericel's Prepaid Assets stood at $4.8 million in 2022, then surged by 42.68% to $6.9 million in 2023, then rose by 6.33% to $7.3 million in 2024, then grew by 6.27% to $7.7 million in 2025, then rose by 3.18% to $8.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $8.0 million, $7.7 million, and $8.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.99 Mn |
| Dec 31, 2025 | 7.74 Mn |
| Sep 30, 2025 | 8.01 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Mar 31, 2025 | 8.52 Mn |
| Dec 31, 2024 | 7.29 Mn |
| Sep 30, 2024 | 7.88 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Mar 31, 2024 | 7.78 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 5.04 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 4.41 Mn |
| Jun 30, 2022 | 4.81 Mn |
| Mar 31, 2022 | 5.09 Mn |
| Dec 31, 2021 | 4.25 Mn |
| Sep 30, 2021 | 4.69 Mn |
| Jun 30, 2021 | 2.85 Mn |
| Mar 31, 2021 | 4.21 Mn |
| Dec 31, 2020 | 3.89 Mn |
| Sep 30, 2020 | 3.59 Mn |
| Jun 30, 2020 | 2.90 Mn |
| Mar 31, 2020 | 3.50 Mn |
| Dec 31, 2019 | 2.95 Mn |
| Sep 30, 2019 | 3.27 Mn |
| Jun 30, 2019 | 2.17 Mn |
| Mar 31, 2019 | 2.68 Mn |
| Dec 31, 2018 | 2.85 Mn |
| Sep 30, 2018 | 2.34 Mn |
| Jun 30, 2018 | 1.33 Mn |
| Mar 31, 2018 | 1.36 Mn |
| Dec 31, 2017 | 1.58 Mn |
| Sep 30, 2017 | 1.37 Mn |
| Jun 30, 2017 | 1.12 Mn |
| Mar 31, 2017 | 1.02 Mn |
| Dec 31, 2016 | 1.16 Mn |
| Sep 30, 2016 | 741,000.00 |
| Jun 30, 2016 | 1.05 Mn |
| Mar 31, 2016 | 662,000.00 |
| Dec 31, 2015 | 464,000.00 |
| Sep 30, 2015 | 514,000.00 |
| Jun 30, 2015 | 2.27 Mn |
| Mar 31, 2015 | 845,000.00 |
| Dec 31, 2014 | 1.04 Mn |
| Sep 30, 2014 | 1.47 Mn |
| Jun 30, 2014 | 610,000.00 |
| Mar 31, 2014 | 400,000.00 |
| Dec 31, 2013 | 409,000.00 |
| Sep 30, 2013 | 545,000.00 |
| Jun 30, 2013 | 236,000.00 |
| Mar 31, 2013 | 300,000.00 |
| Dec 31, 2012 | 352,000.00 |
| Sep 30, 2012 | 364,000.00 |
| Jun 30, 2012 | 455,000.00 |
| Mar 31, 2012 | 453,000.00 |
| Dec 31, 2011 | 636,000.00 |
| Sep 30, 2011 | 622,000.00 |
| Jun 30, 2011 | 524,000.00 |
| Dec 31, 2010 | 426,000.00 |